KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Shares Outstanding (Weighted Average) (2016 - 2025)

Cme (CME) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $359.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) changed 0.07% to $359.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $359.6 million, a 0.07% change, with the full-year FY2025 number at $359.6 million, changed 0.07% from a year prior.
  • Shares Outstanding (Weighted Average) was $359.6 million for Q4 2025 at Cme, roughly flat from $359.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $359.7 million in Q3 2025 to a low of $358.1 million in Q1 2021.
  • A 5-year average of $359.0 million and a median of $359.0 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): rose 0.17% in 2021, then rose 0.07% in 2023.
  • Cme's Shares Outstanding (Weighted Average) stood at $358.3 million in 2021, then grew by 0.1% to $358.7 million in 2022, then rose by 0.09% to $359.0 million in 2023, then grew by 0.1% to $359.4 million in 2024, then increased by 0.07% to $359.6 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Shares Outstanding (Weighted Average) are $359.6 million (Q4 2025), $359.7 million (Q3 2025), and $359.7 million (Q2 2025).